Using hydrothermal techniques, a novel synthetic approach to prepare ruthenium nanoparticles has been developed. At 180 degrees C and under autogenous pressure, starting from an aqueous solution of ruthenium trichloride, the method yielded nanoparticles whose form and size both depended on the reducing agent: sodium citrate (hexagonal shaped nanocrystals, 1-20 nm), ascorbic acid (spherical nanoparticles, 3-5 nm) and succinic acid (spherical nanoparticles, 1-120 nm). Depending on the reaction variables, the nature and concentration of partially reduced species determines the characteristics of the final products. HRTEM image analysis along with the simulation techniques were stabilized preferential growth of nanoparticles on specific directions. Ruthenium samples have been investigated by Temperature-Programmed Reduction (TPR) showing that the reduction temperature of nanoparticles is correlated to their nanocrystalline size.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1166/jnn.2016.10862 | DOI Listing |
ACS Nano
January 2025
Department of Chemical Engineering and SUNCAT Center for Interface Science and Catalysis, Stanford University, Stanford, California 94305, United States.
Carbon capture and utilization involve multiple energy- and cost-intensive steps. Dual-function materials (DFMs) can reduce these demands by coupling CO adsorption and conversion into a single material with two functionalities: a sorbent phase and a metal for catalytic CO conversion. The role of metal catalysts in the conversion process seems salient from previous work, but the underlying mechanisms remain elusive and deserve deeper investigation to achieve maximum utilization of the two phases.
View Article and Find Full Text PDFNanoscale
January 2025
McMaster University, Department of Engineering Physics, Hamilton, ON M8S 4K1, Canada.
Biosens Bioelectron
December 2024
Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China. Electronic address:
MicroRNA (miRNA) imaging in living cells is paramount for comprehending its dynamic functions and profiles, offering valuable insights into miRNA-related cellular processes. However, this remains challenging due to limited transfection agents and the low abundance of miRNAs. Herein, a smart nanosystem was proposed for miRNA imaging in living cells by ingeniously integrating cyclometalated ruthenium (II) nanoparticles (RuNPs) with a catalyzed hairpin assembly (CHA) strategy.
View Article and Find Full Text PDFJ Colloid Interface Sci
December 2024
School of Mechanical Engineering, Qinghai University, Xining 810016, PR China. Electronic address:
Ensuring Ruthenium-based (Ru) catalysts with high metal utilization is a potential and challenging strategy for designing and constructing high catalytic activity electrocatalysts for hydrogen evolution reaction (HER). Herein, Ruthenium single atoms (SA) and Ruthenium nanoparticles (NPs) are simultaneously anchored on hierarchically porous carbon via the self-templates method for the first time. Benefiting from the synergetic effect of hierarchically porous carbon and the coexistence of Ru SA and Ru NPs, the Ru/C-800 shows attractive HER catalytic activity in acidic and alkaline solutions, with low overpotentials to drive the current density of 10 mA cm and the smallest Tafel slope.
View Article and Find Full Text PDFAdv Healthc Mater
December 2024
Department of Surgical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, P. R. China.
The discovery of nanozymes has opened new possibilities for tumor therapy. However, their reliance on the tumor microenvironment and limited catalytic efficiency hinder broader applications. In this study, ruthenium-phenanthroline nanoparticles (Ru-Phs) are synthesized by combining ruthenium with phenanthroline and subsequently coloaded with the proton pump inhibitor (PPI) pantoprazole into sodium alginate (ALG) to form a Ru-Phs-PPI-ALG hydrogel for in situ tumor therapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!